CTRI/2021/06/034021
Not yet recruiting
Not Applicable
A Randomised controlled single blinded clinical trial to evaluate the effectiveness of Perfusion Index as a predictor of successful caudal block in children under 5 years
Institute of Anaesthesiology and Critical care1 site in 1 country60 target enrollmentStarted: October 6, 2021Last updated:
Overview
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Institute of Anaesthesiology and Critical care
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- To monitor perfusion index after caudal block at regular time intervals at T0,T3,T5,T10,T15,T20,T30
Overview
Brief Summary
This study is a randomised controlled single blinded clinical trial to evaluate the effectiveness of Perfusion Index as a predictor of successful caudal block in children under 5 years.Perfusion index is measured at baseline and after caudal block in one group and without caudal block in another group.More than 100% Increase in perfusion index will be considered as onset of successful caudal block
Study Design
- Study Type
- Interventional
- Allocation
- Computer generated randomization
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 1.00 Day(s) to 5.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Children under 5 years Elective infraumbilical surgeries ASA PS I.
Exclusion Criteria
- •Parents refusal Allergic to drug Severe cardiovascular, respiratory,renal, neurological, hepatic disease Local infection Bleeding diathesis.
Outcomes
Primary Outcomes
To monitor perfusion index after caudal block at regular time intervals at T0,T3,T5,T10,T15,T20,T30
Time Frame: Baseline,3min,5min,10min,15min,20min,30min and hourly till 6 hours in the recovery room
Secondary Outcomes
- Patient Hemodynamic parameters(Perioperative period)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
A Clinical Study to Evaluate the Efficacy of an Anti-Aging SerumFine LinesWrinklePhotoagingNCT05271136Revision Skincare26
Active, not recruiting
Phase 2
Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate CancerNeoadjuvant Therapy \ High Risk Prostate Cancer \ DocetaxelNCT04869371Hongqian Guo75
Completed
Phase 3
Bioseal Dural Sealing Study BIOS-14-001Benign TumorsMalignant TumorsVascular MalformationNCT03110783Guangzhou Bioseal Biotechnology Co., Ltd.200
Completed
Phase 3
A clinical study to see the effect of Viola Odorata(homoeopathic medicine) in treatment of Chronic BronchitisHealth Condition 1: J42- Unspecified chronic bronchitisCTRI/2023/02/049490Dr Ruchita Jerath30
Not yet recruiting
Not Applicable
A Single-center Study of CM313 in Patients With PemphigusNCT06904040Sichuan Provincial People's Hospital20